Reduced intensity conditioning with Fludarabine, BCNU and Melphalan (FBM) for allogeneic hematopoietic cell transplantation in elderly AML patients: remission status at transplant predicts outcome

被引：0
|
作者：
Wais, V. [1 ]
Kuendgen, L. [2 ]
Bohl, S. [1 ]
von Harsdorf, S. [1 ]
Schlenk, R. F. [1 ]
Doehner, K. [1 ]
Teleanu, V. [1 ]
Bullinger, L. [1 ]
Drognitz, K. [2 ]
Moulin, J. -C. [2 ]
Binnenhei, M. [2 ]
Bentz, M. [2 ]
Doehner, H. [1 ]
Bunjes, D. [1 ]
Ringhoffer, M. [2 ]
Kuchenbauer, F. [1 ]
机构：
[1] Univ Hosp Ulm, Ulm, Germany
[2] Municipal Hosp Karlsruhe, Karlsruhe, Germany
来源：
BONE MARROW TRANSPLANTATION | 2016年 / 51卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P616
引用
收藏
页码：S442 / S443
页数：2
相关论文
共 50 条
  • [31] Reduced intensity conditioning with thiotepa, fludarabine and melphalan for allogeneic transplantation in multiple myeloma.
    Majolino, I
    Arana, MG
    Riccardi, M
    Locasciulli, A
    Bacigalupo, A
    Di Bartolomeo, P
    Scimè, R
    Olivieri, A
    Narni, F
    De Fabritiis, P
    Corradini, P
    BLOOD, 2003, 102 (11) : 465B - 465B
  • [32] Hematopoietic cell transplantation with reduced intensity conditioning regimen using fludarabine/busulfan and fludarabine/melphalan for primary immunodeficiency diseases
    Nishimura, Akira
    Aoki, Yuki
    Ishiwata, Yasuyoshi
    Inoue, Maiko
    Ichimura, Takuya
    Ueyama, Junichi
    Matsumoto, Kazuaki
    Inoue, Kento
    Hiroki, Haruka
    Ono, Shintaro
    Okano, Tsubasa
    Tanaka, Mari
    Miyamoto, Satoshi
    Ashiarai, Miho
    Miyawaki, Reiji
    Yamagishi, Chika
    Tezuka, Mari
    Okawa, Teppei
    Hoshino, Akihiro
    Endo, Akifumi
    Yasuhara, Masato
    Kamiya, Takahiro
    Mitsuiki, Noriko
    Ono, Toshiaki
    Yanagimachi, Masakatsu
    Isoda, Takeshi
    Tomizawa, Daisuke
    Nagasawa, Masayuki
    Kajiwara, Michiko
    Takagi, Masatoshi
    Mizutani, Shuki
    Kanegane, Hirokazu
    Imai, Kohsuke
    Morio, Tomohiro
    BONE MARROW TRANSPLANTATION, 2019, 54 : 390 - 391
  • [33] Reduced-intensity conditioning with thiotepa, fludarabine and melphalan for allogeneic transplantation in multiple myeloma
    Majolino, I
    Arana, MG
    Riccardi, M
    Locasciulli, A
    Bacigalupo, A
    Di Bartolomeo, P
    Scimè, R
    Olivieri, A
    Narni, F
    De Fabritiis, P
    Corradini, P
    BONE MARROW TRANSPLANTATION, 2004, 33 : S37 - S38
  • [34] Reduced-intensity conditioning with thiotepa, fludarabine and melphalan for allogeneic transplantation in multiple myeloma
    Majolino, I
    Carnevalli, E
    Locasciulli, A
    Di Bartolomeo, P
    Scimè, R
    Corradini, P
    Selleri, M
    Narni, F
    Musso, M
    Bregni, M
    Olivieri, A
    De Fabritiis, P
    Pogliani, L
    Ruscio, C
    Bacigalupo, A
    BONE MARROW TRANSPLANTATION, 2006, 37 : S144 - S145
  • [35] Reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation with fludarabine and melphalan is associated with durable disease control in myelodysplastic syndrome
    Nakamura, R.
    Rodriguez, R.
    Palmer, J.
    Stein, A.
    Naing, A.
    Tsai, N.
    Chang, K.
    Slovak, M. L.
    Bhatia, R.
    Spielberger, R.
    Kogut, N.
    Pullarkat, V.
    Kirschbaum, M.
    Forman, S. J.
    O'Donnell, M. R.
    BONE MARROW TRANSPLANTATION, 2007, 40 (09) : 843 - 850
  • [36] Reduced-intensity allogeneic hematopoietic cell transplantation using fludarabine-melphalan conditioning for treatment of mature T-cell lymphomas
    Delioukina, M.
    Zain, J.
    Palmer, J. M.
    Tsai, N.
    Thomas, S.
    Forman, S.
    BONE MARROW TRANSPLANTATION, 2012, 47 (01) : 65 - 72
  • [37] Reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation with fludarabine and melphalan is associated with durable disease control in myelodysplastic syndrome
    R Nakamura
    R Rodriguez
    J Palmer
    A Stein
    A Naing
    N Tsai
    K Chang
    M L Slovak
    R Bhatia
    R Spielberger
    N Kogut
    V Pullarkat
    M Kirschbaum
    S J Forman
    M R O'Donnell
    Bone Marrow Transplantation, 2007, 40 : 843 - 850
  • [38] Reduced-intensity conditioning allogeneic hematopoietic cell transplantation using oral fludarabine as part of the conditioning regimen
    Delgado, Julio
    Marco, Ana
    Moreno, Estela
    Pinana, Jose L.
    Valcarcel, David
    Parody, Rocio
    Sanchez-Gonzalez, Blanca
    Martino, Rodrigo
    Briones, Javier
    Sureda, Anna
    Brunet, Salut
    Sierra, Jorge
    BLOOD, 2007, 110 (11) : 306B - 306B
  • [39] Reduced-intensity conditioning allogeneic hematopoietic cell transplantation using oral fludarabine as part of the conditioning regimen
    Delgado, J.
    Marco, A.
    Moreno, E.
    Pinana, J. L.
    Valcarcel, D.
    Martino, R.
    Briones, J.
    Sureda, A.
    Brunet, S.
    Sierra, J.
    CYTOTHERAPY, 2009, 11 (03) : 356 - 361
  • [40] Total Marrow Lymphoid Irradiation/Fludarabine/Melphalan Conditioning for Allogeneic Hematopoietic Cell Transplantation
    Jensen, Lindsay G.
    Stiller, Tracey
    Wong, Jeffrey Y. C.
    Palmer, Joycelynne
    Stein, Anthony
    Rosenthal, Joseph
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (02) : 301 - 307
12345